إسرائيل - العبرية - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - daptomycin - daptomycin 350 mg/vial - daptomycin

إسرائيل - العبرية - Ministry of Health

k.s.kim international ltd - daptomycin - daptomycin 500 mg/vial - daptomycin

إسرائيل - العبرية - Ministry of Health

tzamal bio-pharma ltd - fosfomycin as sodium - אבקה להכנת תמיסה לאינפוזיה - fosfomycin as sodium 2 g - fosfomycin

إسرائيل - العبرية - Ministry of Health

tzamal bio-pharma ltd - fosfomycin as sodium - אבקה להכנת תמיסה לאינפוזיה - fosfomycin as sodium 4 g - fosfomycin

إسرائيل - العبرية - Ministry of Health

tzamal bio-pharma ltd - fosfomycin as sodium - אבקה להכנת תמיסה לאינפוזיה - fosfomycin as sodium 8 g - fosfomycin

إسرائيل - العبرية - Ministry of Health

rafa laboratories ltd - fosfomycin as trometamol - אבקה להכנת תמיסה - fosfomycin as trometamol 3 g/sachet - fosfomycin - fosfomycin - a single-dose treatment for acute, uncomplicated urinary tract infection and as prophylaxis in diagnostic and surgical transurethral procedures.

إسرائيل - العبرية - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - linezolid - טבליה - linezolid 600 mg - linezolid - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected. zyvoxid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: 1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.

إسرائيل - العبرية - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - linezolid - תמיסה לאינפוזיה - linezolid 2 mg/ml - linezolid - linezolid - therapy is indicated only when an organism resistant to all other antibiotics is suspected. zyvoxid is indicated in adult and pediatric patients for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: 1) pneumonia - community acquired and nosocomial pneumonia including multi drug resistant streptococcus pneumonia (mdrsp). 2) skin and soft tissue infections including diabetic foot infections. 3) enterococcal infections. combination therapy may be indicated if a concomitant gram negative pathogen is documented or suspected.

إسرائيل - العبرية - Ministry of Health

medison pharma ltd - daptomycin 500 mg/vial - lyophilized powder for injection - daptomycin - cubicin (daptomycin for injection) is indicated for the treatment of complicated skin and skin structure infections caused by susceptible strains of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant strains) streptococcus pyogenes streptococcus agalactiae streptococcus dysgalactiae subsp. equisimilis and enterococcus faecalis (vancomycin-susceptible strains only). combination therapy may be clinically indicated if the documented or presumed pathogens include gram-negative or anaerobic organisms. daptomycin is not indicated for the treatment of pneumonia. appropriate specimens for microbiological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to daptomycin. empiric therapy may be initiated while awaiting test results. antimicrobial therapy should be adjusted as needed based upon test results. to reduce the development of drug-resistant bacteria and maintain the effectiveness of cubici

إسرائيل - العبرية - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - linezolid - טבליה - linezolid 600 mg - linezolid